Overview
Financials
Filing timeliness
No financial statement for 2019 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2018, 22 days late).
- 2019not filed
- 201806/08/2019
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2018.
Results vs industry
Industry
- Other specialised wholesale (46.7)
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board is authorized independently. In the case of a multi-member management board, the President of the Management Board is authorized independently, or two members of the management board acting jointly, or a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Barbara Maria Walczakage 78 | 92 | $12,425.72 | 92% |
Others | 8 | $1,080.50 | 8% |
Beneficial owners
No beneficial owners recorded for the company Bolis Pharma.
Debt
5 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Nov 22, 2024 | Discontinued enforcement proceedings | Closed | |
| Apr 30, 2024 | Discontinued enforcement proceedings | Closed | |
| Apr 30, 2024 | Discontinued enforcement proceedings | Closed | |
| Jun 30, 2022 | Discontinued enforcement proceedings | Closed | |
| Dec 22, 2021 | Discontinued enforcement proceedings | Closed |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 23, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $71,025$71,025 | Prezes Banku Gospodarstwa Krajowego | |
| Apr 26, 2017 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $55,584$55,584 | Prezes Banku Gospodarstwa Krajowego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| IMC Impomed CentrumS.A. | $4,447,564.10 | impomed.pl | ||
| Gtm-Mobil M-T T.Walisiewiczsp. k. | $3,438,533.82 | gtmmobil.com.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Petronafsp. z o.o. | $2,499,010.09 | petronaf.com | ||
| Tricopat Globalsp. z o.o. | $1,772,824.41 | tricopatglobal.com | ||
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com |
FAQ
Last updated: 2026-04-24